Nevada Code § 639.23284

Pharmacy located outside Nevada that dispenses prescriptions to patients located in Nevada: Requirements to dispense prescriptions to patients; restrictions on such Canadian pharmacies
Open in Lexace · Ask the AI about this section
1. Every pharmacy located outside Nevada
that dispenses prescriptions to patients located in Nevada:
(a) Shall report to the Board any change of
information that appears on its license and pay the fee required by regulation
of the Board.
(b) Shall make available for inspection all
pertinent records, reports, documents or other material or information required
by the Board.
(c) As required by the Board, must be inspected
by the Board or:
(1) The regulatory board or licensing
authority of the state or country in which the pharmacy is located; or
(2) The Drug Enforcement Administration.
(d) As required by the Board, shall provide the
following information concerning each prescription for a drug that is shipped,
mailed or delivered to a patient located in Nevada:
(1) The name of the patient;
(2) The name of the prescriber;
(3) The number of the prescription;
(4) The date of the prescription;
(5) The name of the drug;
(6) The symptom or purpose for which the
drug is prescribed, if requested by the patient pursuant to NRS 639.2352 ; and
(7) The strength and quantity of the dose.
2. In addition to complying with the
requirements of subsection 1, every Canadian pharmacy which is licensed by the
Board and which has been recommended by the Board pursuant to subsection 4 of NRS 639.2328 for inclusion on the Internet
website established and maintained pursuant to paragraph (i) of subsection 1 of NRS 232.459 that dispenses prescriptions
to a patient located in Nevada shall not sell, distribute or furnish to a
patient located in this State:
(a) A controlled substance;
(b) A prescription drug that has not been
approved by the federal Food and Drug Administration;
(c) A generic prescription drug that has not been
approved by the federal Food and Drug Administration;
(d) A prescription drug for which the federal
Food and Drug Administration has withdrawn or suspended its approval; or
(e) A quantity of prescription drugs at one time
that includes more drugs than are prescribed to the patient as a 3-month supply
of the drugs.

‹ Prev All Nevada sections Next ›


Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.